Works matching IS 2076393X AND DT 2023 AND VI 11 AND IP 5
Results: 132
Vaccines against Tuberculosis: Where Are We Now?
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 1013, doi. 10.3390/vaccines11051013
- By:
- Publication type:
- Article
A Third Dose of SARS-CoV-2 mRNA Vaccine Improves Immune Response in Chronic Kidney Disease Patients.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 1012, doi. 10.3390/vaccines11051012
- By:
- Publication type:
- Article
The Impact of Vaccination on COVID-19 Burden of Disease in the Adult and Elderly Population: A Systematic Review of Italian Evidence.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 1011, doi. 10.3390/vaccines11051011
- By:
- Publication type:
- Article
COVID-19 Vaccination in the WHO African Region: Progress Made in 2022 and Factors Associated.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 1010, doi. 10.3390/vaccines11051010
- By:
- Publication type:
- Article
Flattening the Curve after the Initial Outbreak of Coronavirus Disease 2019: A Data-Driven Modeling Analysis for the Omicron Pandemic in China.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 1009, doi. 10.3390/vaccines11051009
- By:
- Publication type:
- Article
Perceptions and Intention to Get Vaccinated against Mpox among the LGBTIQ+ Community during the 2022 Outbreak: A Cross-Sectional Study in Peru.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 1008, doi. 10.3390/vaccines11051008
- By:
- Publication type:
- Article
Subsequent Immunization of Pigs with African Swine Fever Virus (ASFV) Seroimmunotype IV Vaccine Strain FK-32/135 and by Recombinant Plasmid DNA Containing the CD2v Derived from MK-200 ASFV Seroimmunotype III Strain Does Not Protect from Challenge with ASFV Seroimmunotype III
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 1007, doi. 10.3390/vaccines11051007
- By:
- Publication type:
- Article
Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 1006, doi. 10.3390/vaccines11051006
- By:
- Publication type:
- Article
A Booster with a Genotype-Matched Inactivated Newcastle Disease Virus (NDV) Vaccine Candidate Provides Better Protection against a Virulent Genotype XIII.2 Virus.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 1005, doi. 10.3390/vaccines11051005
- By:
- Publication type:
- Article
Bovine Herpesvirus-4 Based Vaccine Provides Protective Immunity against Streptococcus suis Disease in a Rabbit Model.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 1004, doi. 10.3390/vaccines11051004
- By:
- Publication type:
- Article
Comparison of the Immune Effects of an mRNA Vaccine and a Subunit Vaccine against Herpes Zoster Administered by Different Injection Methods.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 1003, doi. 10.3390/vaccines11051003
- By:
- Publication type:
- Article
The Quantification of Spike Proteins in the Inactivated SARS-CoV-2 Vaccines of the Prototype, Delta, and Omicron Variants by LC–MS.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 1002, doi. 10.3390/vaccines11051002
- By:
- Publication type:
- Article
Adaptation and Validation of a French Version of the Vaccination Attitudes Examination (VAX) Scale.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 1001, doi. 10.3390/vaccines11051001
- By:
- Publication type:
- Article
No Difference in the Prevalence of HIV-1 gag Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 1000, doi. 10.3390/vaccines11051000
- By:
- Publication type:
- Article
A First-in-Human Trial to Evaluate the Safety and Immunogenicity of a G Protein-Based Recombinant Respiratory Syncytial Virus Vaccine in Healthy Adults 18–45 Years of Age.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 999, doi. 10.3390/vaccines11050999
- By:
- Publication type:
- Article
Assessment of Safety and Prophylactic Efficacy of the EpiVacCorona Peptide Vaccine for COVID-19 Prevention (Phase III).
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 998, doi. 10.3390/vaccines11050998
- By:
- Publication type:
- Article
Knowledge and Attitudes towards Human Papillomavirus Vaccination (HPV) among Healthcare Providers Involved in the Governmental Free HPV Vaccination Program in Shenzhen, Southern China.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 997, doi. 10.3390/vaccines11050997
- By:
- Publication type:
- Article
Association between Overweight/Obesity and the Safety and Efficacy of COVID-19 Vaccination: A Systematic Review.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 996, doi. 10.3390/vaccines11050996
- By:
- Publication type:
- Article
Evaluation of IL-35, as a Possible Biomarker for Follow-Up after Therapy, in Chronic Human Schistosoma Infection.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 995, doi. 10.3390/vaccines11050995
- By:
- Publication type:
- Article
The Influence of Recommendation of Medical and Non-Medical Authorities on the Decision to Vaccinate against Influenza from a Social Vaccinology Perspective: Cross-Sectional, Representative Study of Polish Society.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 994, doi. 10.3390/vaccines11050994
- By:
- Publication type:
- Article
HuNoV Non-Structural Protein P22 Induces Maturation of IL-1β and IL-18 and N-GSDMD-Dependent Pyroptosis through Activating NLRP3 Inflammasome.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 993, doi. 10.3390/vaccines11050993
- By:
- Publication type:
- Article
Bioprocessing and the Production of Antiviral Biologics in the Prevention and Treatment of Viral Infectious Disease.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 992, doi. 10.3390/vaccines11050992
- By:
- Publication type:
- Article
IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 991, doi. 10.3390/vaccines11050991
- By:
- Publication type:
- Article
Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 990, doi. 10.3390/vaccines11050990
- By:
- Publication type:
- Article
BNT162b2 COVID-19 Vaccines in Children, Adolescents and Young Adults with Cancer—A 1-Year Follow-Up.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 989, doi. 10.3390/vaccines11050989
- By:
- Publication type:
- Article
A Methodological Framework for Assessing the Benefit of SARS-CoV-2 Vaccination following Previous Infection: Case Study of Five- to Eleven-Year-Olds.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 988, doi. 10.3390/vaccines11050988
- By:
- Publication type:
- Article
Future COVID-19 Booster Vaccine Refusal in Healthcare Workers after a Massive Breakthrough Infection Wave, a Nationwide Survey-Based Study.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 987, doi. 10.3390/vaccines11050987
- By:
- Publication type:
- Article
Impact of COVID-19 Outbreak on Influenza and Pneumococcal Vaccination Uptake: A Multi-Center Retrospective Study.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 986, doi. 10.3390/vaccines11050986
- By:
- Publication type:
- Article
Real-World Effectiveness of Four Types of COVID-19 Vaccines.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 985, doi. 10.3390/vaccines11050985
- By:
- Publication type:
- Article
Estimating the Total Societal Cost of a Hexavalent Vaccine versus a Pentavalent Vaccine with Hepatitis B in South Korea.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 984, doi. 10.3390/vaccines11050984
- By:
- Publication type:
- Article
ANCA Associated Glomerulonephritis Following SARS-CoV-2 Vaccination: A Case Series and Systematic Review.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 983, doi. 10.3390/vaccines11050983
- By:
- Publication type:
- Article
Mucosal Vaccination with Live Attenuated Bordetella bronchiseptica Protects against Challenge in Wistar Rats.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 982, doi. 10.3390/vaccines11050982
- By:
- Publication type:
- Article
Determinants of COVID Vaccination Willingness among Health and Non-Health Studies Students: A Cross-Sectional Study.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 981, doi. 10.3390/vaccines11050981
- By:
- Publication type:
- Article
Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 980, doi. 10.3390/vaccines11050980
- By:
- Publication type:
- Article
Real-World Safety and Efficacy Clinical Data of an Improved Allergen-Specific Immunotherapy Product for the Treatment of Bee Venom Allergy.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 979, doi. 10.3390/vaccines11050979
- By:
- Publication type:
- Article
Results on SARS-CoV-2 mRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 978, doi. 10.3390/vaccines11050978
- By:
- Publication type:
- Article
Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 977, doi. 10.3390/vaccines11050977
- By:
- Publication type:
- Article
A Case-Control Study on Factors of HPV Vaccination for Mother and Daughter in China.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 976, doi. 10.3390/vaccines11050976
- By:
- Publication type:
- Article
Optimizing the Production of gp145, an HIV-1 Envelope Glycoprotein Vaccine Candidate and Its Encapsulation in Guanosine Microparticles.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 975, doi. 10.3390/vaccines11050975
- By:
- Publication type:
- Article
Experiences, Enablers, and Challenges in Service Delivery and Integration of COVID-19 Vaccines: A Rapid Systematic Review.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 974, doi. 10.3390/vaccines11050974
- By:
- Publication type:
- Article
COVID-19 Vaccine Perceptions among Ebola-Affected Communities in North Kivu, Democratic Republic of the Congo, 2021.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 973, doi. 10.3390/vaccines11050973
- By:
- Publication type:
- Article
COVID-19 Prevention Behaviours and Vaccine Acceptability, and Their Association with a Behaviour Change Campaign in Somalia: Analysis of a Longitudinal Cohort.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 972, doi. 10.3390/vaccines11050972
- By:
- Publication type:
- Article
Selection Effects and COVID-19 Mortality Risk after Pfizer vs. Moderna Vaccination: Evidence from Linked Mortality and Vaccination Records.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 971, doi. 10.3390/vaccines11050971
- By:
- Publication type:
- Article
Experimental Medicine for HIV Vaccine Research and Development.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 970, doi. 10.3390/vaccines11050970
- By:
- Publication type:
- Article
Serological Response to SARS-CoV-2 after COVID-19 Vaccination in Lung Cancer Patients: Short Review.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 969, doi. 10.3390/vaccines11050969
- By:
- Publication type:
- Article
Clinical Characteristics of Mild Patients with Breakthrough Infection of Omicron Variant in China after Relaxing the Dynamic Zero COVID-19 Policy.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 968, doi. 10.3390/vaccines11050968
- By:
- Publication type:
- Article
Adolescents' Opinions on COVID-19 Vaccine Hesitancy: Hints toward Enhancing Pandemic Preparedness in the Future.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 967, doi. 10.3390/vaccines11050967
- By:
- Publication type:
- Article
Potential of Nucleic Acid Receptor Ligands to Improve Vaccination Efficacy against the Filarial Nematode Litomosoides sigmodontis.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 966, doi. 10.3390/vaccines11050966
- By:
- Publication type:
- Article
A Plant-Derived Maternal Vaccine against Porcine Epidemic Diarrhea Protects Piglets through Maternally Derived Immunity.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 965, doi. 10.3390/vaccines11050965
- By:
- Publication type:
- Article
Acceptance of COVID-19 Vaccines in India: A Systematic Review and Meta-Analysis.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 964, doi. 10.3390/vaccines11050964
- By:
- Publication type:
- Article